HAL (France)
open access
Epitranscriptomic liquid biopsy: A new paradigm for early detection and management of gastrointestinal cancers
Background Liquid biopsy holds great promise for transforming patient care, yet current biomarkers such as circulating tumor DNA and circulating tumor cells lack sensitivity in early-stage disease. This highlights the need for novel biomarkers capable of detecting subtle molecular alterations preced
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients With Versus Without Intestinal Polyps#847689
- Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device#916233
- Liquid biopsy biomarkers for cancer detection, treatment monitoring, and clinical outcome prediction.#427710
- The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer#1293791
- Circulating Tumor Cells in Lung Cancer#1031132
Record · ID 1390532
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive